Published in Med Microbiol Immunol on June 28, 2003
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol (2011) 1.63
Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health (2010) 1.53
A 'snip' in time: what is the best age to circumcise? BMC Pediatr (2012) 1.36
Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis (2013) 1.33
Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men. Cancer Res (2011) 1.05
Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. Int J Cancer (2008) 1.05
Vaccination against infectious diseases: what is promising? Med Microbiol Immunol (2014) 1.03
NFX1-123 increases hTERT expression and telomerase activity posttranscriptionally in human papillomavirus type 16 E6 keratinocytes. J Virol (2009) 0.93
Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study. J Clin Virol (2013) 0.88
Diagnosis and treatment of penile verrucous carcinoma. Oncol Lett (2015) 0.88
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types. BMC Microbiol (2008) 0.86
Histological characteristics of human papilloma-virus-positive and -negative invasive and in situ squamous cell tumours of the penis. Int J Exp Pathol (2009) 0.86
Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis (2005) 0.85
Molecular prognostic factors in penile cancer. World J Urol (2008) 0.85
Buried penis: An unrecognized risk factor in the development of invasive penile cancer. Can Urol Assoc J (2012) 0.85
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncol Rev (2012) 0.84
Relationship among human papillomavirus infection, p16(INK4a), p53 and NF-κB activation in penile cancer from northern Thailand. Oncol Lett (2010) 0.82
Surgical treatment for 11 cases of penile verrucous carcinoma. Ann Dermatol (2011) 0.82
Prevalence of human papillomavirus infection and phylogenetic analysis of HPV-16 E6 variants among infected women from Northern Brazil. Infect Agent Cancer (2014) 0.81
HPV frequency in penile carcinoma of Mexican patients: important contribution of HPV16 European variant. Int J Clin Exp Pathol (2013) 0.80
Human papillomavirus genotypes in penile cancers from Japanese patients and HPV-induced NF-κB activation. Oncol Lett (2010) 0.80
The impact of smoking on HPV infection and the development of anogenital warts. Int J Colorectal Dis (2014) 0.79
Human papillomavirus infections in primary care. Clin Med Res (2007) 0.78
Epigenetic mechanisms in penile carcinoma. Int J Mol Sci (2013) 0.77
NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes. J Virol (2013) 0.76
Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011. BMC Public Health (2016) 0.75
Spectrum and progression of disease from condyloma to aggressive anogenital squamous cell carcinoma in 3 HIV-positive patients. JAAD Case Rep (2016) 0.75
The Most Common Type of HPV in Cervical Cancer in Women with Atypical Squamous Cell of Undetermined Significance (ASCUS) in Pap Smear in Iran-Yazd. Int J Biomed Sci (2015) 0.75
Impact of Serum Antibodies to HPV Serotypes 6, 11, 16, and 18 to Risks of Subsequent Genital HPV Infections in Men: The HIM Study. Cancer Res (2016) 0.75
Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data. BMC Infect Dis (2017) 0.75
Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts. Virusdisease (2017) 0.75
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A (1983) 6.81
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol (1977) 5.21
Male circumcision: assessment of health benefits and risks. Sex Transm Infect (1998) 4.59
Natural history of genital warts. Br J Vener Dis (1971) 4.22
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol (1995) 3.81
Epidemiology of genital human papillomavirus infection. Epidemiol Rev (1988) 3.32
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Human papillomaviruses. Annu Rev Microbiol (1994) 2.88
Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol (1995) 2.46
High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med (1987) 2.37
Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid papulosis. Int J Cancer (1983) 2.30
Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (2000) 2.23
The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol (1995) 2.21
Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol (1999) 2.13
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect (2000) 1.80
Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol (2001) 1.67
Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer (1986) 1.67
Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA (1989) 1.65
Bowenoid papulosis of the genitalia. Arch Dermatol (1979) 1.62
Cervical cancer. NIH Consens Statement (1998) 1.61
Heterogeneity of human papillomavirus DNA in a patient with Bowenoid papulosis that progressed to squamous cell carcinoma. Br J Dermatol (1998) 1.42
Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature. J Invest Dermatol (1985) 1.42
Cervical papillomavirus infection and intraepithelial neoplasia: a study of male sexual partners. Obstet Gynecol (1984) 1.41
Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol (1986) 1.26
Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol (1985) 1.24
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19
Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis (1995) 1.16
Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol (2002) 1.14
Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer (1994) 1.13
Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol (1997) 1.08
Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst (1995) 1.07
Risk factors for the acquisition of genital warts: are condoms protective? Sex Transm Infect (1999) 1.07
Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer (2001) 1.05
PEARLY PENILE PAPULES. Arch Dermatol (1964) 1.05
Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol (1997) 1.04
Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J Med Virol (2000) 1.03
Verrucous carcinoma arising in pseudoepitheliomatous keratotic and micaceous balanitis, without evidence of human papillomavirus. Br J Dermatol (2000) 1.00
Bowenoid papulosis of the penis. Cancer (1978) 1.00
The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol (1997) 0.95
Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol (1998) 0.95
Human papillomavirus DNA sequences in penile carcinomas in Brazil. Int J Cancer (1986) 0.93
Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: a study of 41 cases using PCR. J Clin Pathol (1994) 0.92
High prevalence of human papillomavirus type 16 infection among children. J Med Virol (2000) 0.92
Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol (1993) 0.92
Carcinoma of the penis: analysis of 219 cases. Cancer (1982) 0.91
Morphological features of epithelial abnormalities and precancerous lesions of the penis. Scand J Urol Nephrol Suppl (2000) 0.89
Epidemiology of cancer of the penis. Recent Results Cancer Res (1977) 0.88
Verrucous carcinoma of the penis: importance of human papillomavirus typing for diagnosis and therapeutic decision. Eur Urol (1992) 0.87
Association of human papillomavirus type 11 with carcinoma of the penis. Urology (1998) 0.86
Detection of human papillomavirus in verrucous carcinoma from HIV-seropositive patients. J Cutan Pathol (1998) 0.84
Role of human papillomavirus typing in diagnosis and clinical decision making for a giant verrucous genital lesion. Urology (1999) 0.82
Detection of human papillomavirus DNA in penile lesions histologically negative for condylomata. Analysis by in situ hybridization and the polymerase chain reaction. Am J Surg Pathol (1990) 0.81
The management and prevention of premalignant penile lesions. Scand J Urol Nephrol Suppl (2000) 0.80
Metastatic periungual squamous cell carcinoma: detection of human papillomavirus type 35 RNA in the digital tumor and axillary lymph node metastases. J Am Acad Dermatol (1996) 0.79
Genital human papillomavirus infection and associated penile intraepithelial neoplasia in males infected with the human immunodeficiency virus. Acta Cytol (2000) 0.76
[Condylomata acuminata and other HPV-associated manifestations of the genitals and urethra. Guideline of the German STD Society (DSTG)]. Hautarzt (2001) 0.75
Human immunodeficiency virus infection and female lower genital tract malignancy. Curr Opin Obstet Gynecol (1999) 0.75
HPV-16-related Bowenoid papulosis. Lancet (1985) 0.75
Anal verrucous carcinoma and penile condylomata acuminata. Dermatology (2000) 0.75
Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol (1984) 4.13
Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med (2004) 4.10
Human papilloma viruses (HPV): characterization of four different isolates. Virology (1977) 2.99
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS (1997) 2.82
Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol (1998) 2.65
Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med (2003) 2.07
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry (2010) 2.00
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Int J Cancer (1981) 1.99
Human papilloma virus 5-DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types. Cancer Res (1983) 1.95
Human papillomaviruses and genital cancer. Adv Cancer Res (1987) 1.88
Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri. Int J Cancer (1988) 1.79
Parental alcohol use disorders and alcohol use and disorders in offspring: a community study. Psychol Med (2002) 1.71
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J (1994) 1.71
Epidermodysplasia verruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. J Virol (1986) 1.65
Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity. J Virol (1989) 1.64
Comparative evaluation of different enzyme-linked immunosorbent assay systems for the detection of staphylococcal enterotoxins A, B, C, and D. J Clin Microbiol (1984) 1.61
The natural course of cannabis use, abuse and dependence over four years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend (2001) 1.52
Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer (1994) 1.49
One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety (2001) 1.46
Interactive Volume Exploration of Petascale Microscopy Data Streams Using a Visualization-Driven Virtual Memory Approach. IEEE Trans Vis Comput Graph (2012) 1.45
Recurrent brief depressive disorder reinvestigated: a community sample of adolescents and young adults. Psychol Med (2003) 1.44
Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand Suppl (2000) 1.41
Female barn owls (Tyto alba) advertise good genes. Proc Biol Sci (2000) 1.39
Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int J Cancer (1989) 1.35
Differential regulation of papilloma virus early gene expression in transformed fibroblasts and carcinoma cell lines. EMBO J (1986) 1.35
Papilloma virus-induced tumors contain a virus-specific transcript. Virology (1982) 1.32
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol (2000) 1.31
"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome. J Neurol (2005) 1.31
Characterization of human papillomavirus type 13 from focal epithelial hyperplasia Heck lesions. J Virol (1983) 1.28
Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer (1989) 1.27
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol (1999) 1.26
Correlation between human papillomavirus (HPV) type and histology of warts. J Invest Dermatol (1982) 1.25
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Methods of isolation, purification and quantitation of bovine immunoglobulins: a technical review. Zentralbl Veterinarmed B (1976) 1.25
Recall and dating of psychiatric symptoms. Test-retest reliability of time-related symptom questions in a standardized psychiatric interview. Arch Gen Psychiatry (1989) 1.24
Molecular cloning and characterization of the DNAs of human papillomaviruses 19, 20, and 25 from a patient with epidermodysplasia verruciformis. J Virol (1984) 1.23
Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J Immunol (1995) 1.22
Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol (2000) 1.19
Human papillomavirus type 13 and pygmy chimpanzee papillomavirus type 1: comparison of the genome organizations. Virology (1992) 1.18
Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav (2013) 1.15
Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res (1990) 1.14
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein. Int J Cancer (1993) 1.13
A protein related to p21-activated kinase (PAK) that is involved in neurogenesis in the Drosophila adult central nervous system. Curr Biol (1998) 1.12
Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol (2010) 1.09
Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol (1990) 1.08
Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch Dermatol Res (1986) 1.08
Characterization of human papillomavirus 3 in warts of a renal allograft patient. J Invest Dermatol (1979) 1.08
Extrachromosomal bovine papillomavirus type 1 DNA in hamster fibromas and fibrosarcomas. Virology (1981) 1.06
Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol (1999) 1.06
Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol (2000) 1.06
Late promoter of human papillomavirus type 8 and its regulation. J Virol (1992) 1.06
Diversity of human papillomavirus types in periungual squamous cell carcinoma. Br J Dermatol (2009) 1.05
Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. J Psychopharmacol (2008) 1.04
CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma. J Immunol (1999) 1.04
Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J Virol (1992) 1.03
Duplication of enhancer sequences in human papillomavirus 6 from condylomas of the mamilla. Virology (1989) 1.03
Involvement of human papillomavirus type 8 genes E6 and E7 in transformation and replication. J Virol (1988) 1.03
Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol (1988) 1.02
p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load. Br J Dermatol (2007) 1.02
Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol (1997) 1.00
Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology (1995) 1.00
Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) substance use sections. Eur Addict Res (1998) 1.00
Genetic relationship among human papillomaviruses associated with benign and malignant tumours of patients with epidermodysplasia verruciformis. J Gen Virol (1987) 1.00
Cell differentiation-related gene expression of human papillomavirus 33. Med Microbiol Immunol (1990) 1.00
Inducible nitric oxide synthase in cattle. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J Immunol (1995) 0.99
Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand (2000) 0.99
Detection of new human papillomavirus sequences in skin lesions of a renal transplant recipient and characterization of one complete genome related to epidermodysplasia verruciformis-associated types. J Gen Virol (1998) 0.98
Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet (2000) 0.97
Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer (2002) 0.97
Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production. J Immunol (2000) 0.96
Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis. J Virol (1997) 0.95
Demonstration of human papillomavirus DNA in two keratoacanthomas. Arch Dermatol Res (1986) 0.95
["Generalized anxiety and depression in primary care" (GAD-P). Study design and methods]. Fortschr Med Orig (2001) 0.95
In vitro expressed HPV 8 E6 protein does not bind p53. Arch Virol (1992) 0.95
Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women. J Gen Virol (2000) 0.95
E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J Virol (1996) 0.95
The waxing and waning of mental disorders: evaluating the stability of syndromes of mental disorders in the population. Compr Psychiatry (2000) 0.94
The E7 protein of human papillomavirus 8 is a nonphosphorylated protein of 17 kDa and can be generated by two different mechanisms. Virology (1990) 0.94
HPV 1 DNA in lesions of focal epithelial hyperplasia Heck. Arch Dermatol Res (1980) 0.94
CD36-mediated signal transduction in human monocytes by anti-CD36 antibodies but not by anti-thrombospondin antibodies recognizing cell membrane-bound thrombospondin. Biochem Biophys Res Commun (1991) 0.94
Adsorption of a phage tail-like bacteriocin to isolated lipopolysaccharide of Rhizobium. J Gen Virol (1977) 0.94
Low-affinity E2-binding site mediates downmodulation of E2 transactivation of the human papillomavirus type 8 late promoter. J Virol (1994) 0.93
Seroepidemiological studies of human papilloma virus (HPV-1) infections. Int J Cancer (1978) 0.93
Immunoelectrophoretic determination of albumin and IgG in serum and cerebrospinal fluid in dogs with neurological diseases. Res Vet Sci (1984) 0.93
Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16. J Gen Virol (1999) 0.92
Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking. Genes Brain Behav (2009) 0.92
[Aim, design and methods of the "Hypertension and diabetes screening and awareness" -- (HYDRA) study]. Fortschr Med Orig (2003) 0.92
Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol (1997) 0.91
Monochloroacetic acid and 60% salicylic acid as a treatment for simple plantar warts: effectiveness and mode of action. Br J Dermatol (1988) 0.91
Test-retest reliability of a standardized psychiatric interview (DIS/CIDI). Eur Arch Psychiatry Neurol Sci (1987) 0.91
Partial characterization of a new type of bovine papilloma viruses. Virology (1979) 0.90
Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1. Med Microbiol Immunol (1978) 0.90
The Munich Personality Test (MPT)--a short questionnaire for self-rating and relatives' rating of personality traits: formal properties and clinical potential. Eur Arch Psychiatry Neurol Sci (1988) 0.90
Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor. J Virol (1994) 0.89
Partial characterization of a canine oral papillomavirus. Virology (1980) 0.89
Constitutive transcriptional activator of Epidermodysplasia verruciformis-associated human papillomavirus 8. Virology (1993) 0.89
Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes. Int J Cancer (1999) 0.89
[Affective, somatoform and anxiety disorders in Germany--initial results of an additional federal survey of "psychiatric disorders"]. Gesundheitswesen (1999) 0.89